A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
- Conditions
- Hereditary Angioedema (HAE)
- Registration Number
- NCT01541423
- Lead Sponsor
- Shire
- Brief Summary
This observational (non-interventional) study is being conducted to characterize the safety and use of CINRYZE in routine clinical practice when administered for (1) routine prevention of angioedema attacks, (2) pre-procedure prevention of angioedema attacks, and/or (3) treatment of angioedema attacks.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 83
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse drug reactions 12 months Occurrence of pregnancy 12 months Incidence of thrombotic/thromboembolic events 12 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (20)
Universitair Ziekenhuis Antwerpen (UZA)
🇧🇪Antwerp, Edegem, Belgium
Clinic St-Luc University Hospital
🇧🇪Brussels, Belgium
CHU d'Angers
🇫🇷Angers, France
Hôpital Claude-Huriez
🇫🇷Lille, France
Immunologie Clinique et Allergologie
🇫🇷Nancy, France
Hôpital Saint Antoine
🇫🇷Paris, France
Université Paris Descartes
🇫🇷Paris, France
Allergie-Centrum-Charite
🇩🇪Berlin, Germany
Universitätsklinik Essen
🇩🇪Essen, Germany
Johann Wolfgang Goethe Universität
🇩🇪Frankfurt, Germany
Scroll for more (10 remaining)Universitair Ziekenhuis Antwerpen (UZA)🇧🇪Antwerp, Edegem, Belgium